DiaMedica Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

DiaMedica Therapeutics

09/11/2022 23:29

* DiaMedica Therapeutics Inc  DMAC.OQ  reported a quarterly
adjusted loss of 12 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 15 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * DiaMedica Therapeutics Inc's reported EPS for the quarter
was a
loss of 12 cents​.
    * The mean earnings estimate of analysts had risen by
about 22.4%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * DiaMedica Therapeutics Inc shares had held steady so far
this
quarter and lost 66.8% so far this year.
    * The company reported a quarterly loss of $3.06 million.
    * Wall Street's median 12-month price target for DiaMedica
Therapeutics Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 11:29 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.15          -0.12          Beat
 Jun. 30 2022      -0.18          -0.13          Beat
 Mar. 31 2022      -0.21          -0.13          Beat
 Dec. 31 2021      -0.18          -0.10          Beat